RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0043-1771366
Paraspinal Desmoid Tumor in a Pediatric Patient with No Surgical History: A Case Report
Authors
Abstract
Desmoid tumors are locally aggressive, benign neoplasms originating in connective tissues. Although the exact pathophysiology remains unknown, antecedent trauma or surgery are believed to be important contributing factors. The occurrence of paraspinal desmoid tumor in pediatric patients is extremely uncommon. Here, we present an exceedingly rare case of a pediatric patient with no surgical or family history who developed a paraspinal desmoid tumor.
A 9-year-old female patient presented with 4 months of progressive back pain, right lower extremity weakness, and numbness. Spinal imaging revealed a left epidural paraspinal mass compressing her thoracic spinal cord and extending into the left thoracic cavity. A multidisciplinary approach with neurosurgery and thoracic surgery enabled gross total resection of the lesion. The patient had complete resolution of her symptoms with no signs of residual tumor on postoperative imaging. Pathology revealed a desmoid tumor that avidly stained for beta-catenin. On her last follow-up, she developed a recurrence, to which she was started on sorafenib therapy.
Desmoid tumors are rare connective tissue neoplasms that often occur after local tissue trauma, such as that caused by surgery. This report presents a rare case of a pediatric paraspinal desmoid tumor that occurred in a patient with no surgical or family history. Such tumors should undergo surgical resection for symptomatic relief and tissue diagnosis. Close clinical and radiographic surveillance are essential in these patients due to the high recurrence rates of desmoid tumor.
Keywords
desmoid tumor - epidural mass - wound healing - WNT pathway - beta-catenin - familial adenomatous polyposis - sorafenib* These authors contributed equally and retain the first authorship.
Publikationsverlauf
Artikel online veröffentlicht:
16. April 2024
© 2024. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 de Camargo VP, Keohan ML, D'Adamo DR. et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer 2010; 116 (09) 2258-2265
- 2 Master SR, Mangla A, Puckett Y, Shah C. Desmoid Tumor. Treasure Island, FL: StatPearls; 2021
- 3 Skubitz KM. Biology and treatment of aggressive fibromatosis or desmoid tumor. Mayo Clin Proc 2017; 92 (06) 947-964
- 4 Martínez Trufero J, Pajares Bernad I, Torres Ramón I, Hernando Cubero J, Pazo Cid R. Desmoid-type fibromatosis: who, when, and how to treat. Curr Treat Options Oncol 2017; 18 (05) 29
- 5 Lazar AJ, Tuvin D, Hajibashi S. et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 2008; 173 (05) 1518-1527
- 6 Penel N, Chibon F, Salas S. Adult desmoid tumors: biology, management and ongoing trials. Curr Opin Oncol 2017; 29 (04) 268-274
- 7 Righetti AEM, Jacomini C, Parra RS, de Almeida ALNR, Rocha JJR, Féres O. Familial adenomatous polyposis and desmoid tumors. Clinics (São Paulo) 2011; 66 (10) 1839-1842
- 8 Timbergen MJM, van de Poll-Franse LV, Grünhagen DJ. et al. Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study. Qual Life Res 2018; 27 (12) 3097-3111
- 9 Honeyman JN, Quaglia MP. Desmoid tumors in the pediatric population. Cancers (Basel) 2012; 4 (01) 295-306
- 10 Friede RL, Pollak A. Neurosurgical desmoid tumors: presentation of four cases with a review of the differential diagnoses. J Neurosurg 1979; 50 (06) 725-732
- 11 Gupta A, Batta NS, Batra V. Postoperative recurrent paraspinal fibromatosis after resection of cervical meningioma and review of literature. Indian J Radiol Imaging 2021; 31 (02) 514-518
- 12 Kawashima A, Fishman EK, Hruban RH, Kuhlman JE. Intrathoracic paraspinal desmoid with intracanalicular extension: computed tomography and magnetic resonance imaging findings. Orthopedics 2000; 23 (04) 381-382
- 13 Ko SF, Ng SH, Hsiao CC. et al. Juvenile fibromatosis of the posterior mediastinum with intraspinal extension. AJNR Am J Neuroradiol 1996; 17 (03) 522-524
- 14 Kriss TC, Warf BC. Cervical paraspinous desmoid tumor in a child: case report. Neurosurgery 1994; 35 (05) 956-959 , discussion 959
- 15 McCabe FJ, Hussey AJ, McCabe JP. A rare paraspinal desmoid tumour following instrumented scoliosis correction in an adolescent. Case Rep Orthop 2021; 6665330
- 16 Shindle MK, Khanna AJ, McCarthy EF, O'Neill PJ, Sponseller PD. Desmoid tumor of the spinal canal causing scoliosis and paralysis. Spine 2002; 27 (12) E304-E307
- 17 Gounder MM, Mahoney MR, Van Tine BA. et al. Sorafenib for advanced and refractory desmoid tumors. N Engl J Med 2018; 379 (25) 2417-2428
- 18 Alexander F. Neuroblastoma. Urol Clin North Am 2000; 27 (03) 383-392
- 19 Bohl MA, Leveque JC, Bayles S, Sethi R. Postoperative development of desmoid tumor after surgical correction of adult spinal deformity: case report and review of literature. World Neurosurg 2019; 128: 4-10
- 20 Chu KF, Samara MS, Laver N, Wein RO. A rare presentation of a large extra-abdominal desmoid tumor of the posterior neck and back. Am J Otolaryngol 2013; 34 (06) 727-730
- 21 Cohen S, Ad-El D, Benjaminov O, Gutman H. Post-traumatic soft tissue tumors: case report and review of the literature a propos a post-traumatic paraspinal desmoid tumor. World J Surg Oncol 2008; 6: 28
- 22 Eksi MS, Turkoz HK, Eksi E, Akakin A, Toktas ZO, Konya D. Locally aggressive de novo spinal fibromatosis: case report and review of the literature. Turk Neurosurg 2015; 25 (05) 818-823
- 23 Furlan JC, Valiante T, Dickson B, Kiehl TR. Paraspinal desmoid-type fibromatosis as a cause of low back pain. Spine J 2013; 13 (12) 1958-1959
- 24 Goldstein A, Hoang S, Miller DC, Mesfin FB. Extra-abdominal desmoid tumor mimicking cervical spine schwannoma. Cureus 2018; 10 (08) e3145
- 25 Graeber GM, Seyfer AE, Shriver CD, Awan M. Desmoid tumor of the paraspinous muscle involving the chest wall. Mil Med 1985; 150 (08) 458-461
- 26 Güzey FK, Emel E, Bas NS, Ozkan N, Turgut H, Sel B. Aggressive postoperative lumbar fibromatosis after the placement of instrumentation for treatment of spondylolisthesis. Case report. J Neurosurg Spine 2006; 4 (04) 338-341
- 27 Hara R, Matsuguma H, Suzuki H. et al. Desmoid tumor presenting as a superior sulcus tumor: a unique bone change in the vertebral body. Ann Thorac Surg 2007; 84 (05) 1752-1754
- 28 Lee JH, Paeng SH, Cho HJ, Kim ST, Lee WH. Desmoid fibromatosis in the multifidus muscle misdiagnosed as intramuscular schwannoma by incisional biopsy: a case report. Korean J Neurotrauma 2021; 17 (02) 212-216
- 29 Lee YC, Lee JW. Innovative treatment for huge nuchal desmoid tumour: a case report with a 2-year follow-up. J Plast Reconstr Aesthet Surg 2010; 63 (08) e622-e626
- 30 Lynch JJ, Parvizi J, Scheithauer BW, Krauss WE. Development of postoperative fibromatosis after resection of an intraspinal meningioma. Case report. J Neurosurg 1999; 90 (01) 121-124
- 31 Maurer F, Horst F, Pfannenberg C, Wehrmann M. Multifocal extra-abdominal desmoid tumor–diagnostic and therapeutic problems. Arch Orthop Trauma Surg 1996; 115 (06) 359-362
- 32 Oberthaler W, Rhomberg W. Aggressive fibromatosis. A rare cause for lumbar bulging. Arch Orthop Trauma Surg 1988; 107 (06) 388-390
- 33 Puvanesarajah V, Lina IA, Liauw JA, Hsu W, Burger PC, Witham TF. Desmoid tumor formation following posterior spinal instrumentation placement. Evid Based Spine Care J 2013; 4 (02) 137-142
- 34 Shakur SF, Takagi I, Jacobsohn JA, Golden BM, Karahalios DG. Spinal fibromatosis: a report of two cases and review of the literature. Spine J 2013; 13 (08) e1-e6
- 35 Sonmez E, Altinors N, Gulsen S, Ozen O. Extraabdominal desmoid tumor appearing following resection of thoracolumbar schwannoma. Turk Neurosurg 2011; 21 (02) 246-248
- 36 Wyler AR, Harris AB. Recurrent desmoid tumor following cervical laminectomy. Case report. J Neurosurg 1973; 39 (01) 114-116
- 37 Ganeshan D, Amini B, Nikolaidis P, Assing M, Vikram R. Current update on desmoid fibromatosis. J Comput Assist Tomogr 2019; 43 (01) 29-38
- 38 Umer M, Saeed J, Zahid N. Aggressive fibromatosis in pediatric population-a case series. Int J Surg Case Rep 2018; 52: 45-48
- 39 Lacayo EA, Glastonbury CM, Hoang JK, Magliocca KR, Hill KL, Hudgins PA. Deep neck fibromatosis after diskectomy and cervical fusion: case series and review of the literature. AJR Am J Roentgenol 2016; 206 (05) 1068-1072
- 40 Mujtaba B, Call C, Rowland F. et al. Desmoid fibromatosis following surgical resection of spinal meningioma. Radiol Case Rep 2020; 15 (06) 697-701
- 41 Schlag H, Neuhoff J, Castein J, Hoffmann C, Kandziora F. Sporadic desmoid fibromatosis of the neck after dorsal spondylodesis of the cervical spine. Surg Neurol Int 2022; 13: 64
- 42 Schlemmer M. Desmoid tumors and deep fibromatoses. Hematol Oncol Clin North Am 2005; 19 (03) 565-571 , vii–viii
- 43 Cheon SS, Cheah AY, Turley S. et al. beta-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci U S A 2002; 99 (10) 6973-6978
- 44 Tejpar S, Nollet F, Li C. et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999; 18 (47) 6615-6620
- 45 Peng PD, Hyder O, Mavros MN. et al. Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Ann Surg Oncol 2012; 19 (13) 4036-4042
- 46 Orbach D, Brennan B, Bisogno G. et al. The EpSSG NRSTS 2005 treatment protocol for desmoid-type fibromatosis in children: an international prospective case series. Lancet Child Adolesc Health 2017; 1 (04) 284-292
- 47 Desmoid Tumor Working Group. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer 2020; 127: 96-107
- 48 Skapek SX, Ferguson WS, Granowetter L. et al; Pediatric Oncology Group. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol 2007; 25 (05) 501-506
- 49 Sparber-Sauer M, Orbach D, Navid F. et al. Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis. Br J Cancer 2021; 124 (10) 1637-1646
- 50 Kim A, Widemann BC, Krailo M. et al. Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: a report from the Children's Oncology Group. Pediatr Blood Cancer 2015; 62 (09) 1562-1566
- 51 Gounder MM, Lefkowitz RA, Keohan ML. et al. Activity of Sorafenib against desmoid tumor/deep fibromatosis. Clin Cancer Res 2011; 17 (12) 4082-4090
- 52 Shah DR, Dholakia S, Shah RR. Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients. Drug Saf 2014; 37 (03) 135-149
- 53 Brose MS, Frenette CT, Keefe SM, Stein SM. Management of sorafenib-related adverse events: a clinician's perspective. Semin Oncol 2014; 41 (Suppl. 02) S1-S16